Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the relative bioavailability of one 15 mg
Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam)
Tablet (Boehringer Ingelheim Pharmaceuticals Inc., USA) under fasting conditions.